Imprimed
ImpriMed, located in Mountain View, CA, specializes in personalized cancer treatment solutions for canine and feline lymphoma and leukemia through advanced AI-driven drug response predictions. By testing live cancer cells, they tailor treatment plans to optimize effectiveness and improve outcomes, providing veterinarians and pet owners with critical insights in a timely manner.
The company combines cutting-edge laboratory techniques, such as flow cytometry and immunoprofiling, with artificial intelligence to deliver precise recommendations for chemotherapy options. This innovative approach not only saves time and costs but also enhances the decision-making process for veterinarians and pet parents navigating cancer treatment for their beloved pets.
Generated from the website
